Molecular Imaging

The new cancer center paradigm provides genetic tests not just for experimental research, but as a clinical standard. In this glimpse by Bloomberg, Memorial Sloan Kettering Cancer Center shows off a new laboratory opened just weeks ago where patients' biopsies will be tested for 341 mutations associated with disease.

T cell immunotherapy prompted a striking response from three out of nine women with advanced cervical cancer, including one who had extensive metastases, according to new data from the National Cancer Institute. This could offer an alternative treatment option for women with few choices remaining.

Shakespeare called King Richard III a hunchback, but new genetic and reconstructive CT data show this story had more of a twist. Until recently, the exact nature and whereabouts of Richard's physical deformity was a mystery. While questions still daunt researchers, a compelling picture of the monarch's spine has emerged.

In this video, BBC reporter Fergus Walsh is the first to undergo an MRI scan as part of the largest scan study to date and describes how the study is evolving.

Watch a fly-through of Glass Brain, a 3D imagining of the human brain by researchers at the University of California San Francisco. This video shows the 3D brain model made possible by electroencephalography data and white matter tract reconstruction from MRI diffusion tensor imaging. UCSF is using the technology to research possible treatments for neurodegenerative disease.

The human genome was first mapped just a little over a decade ago. Its 3 billion bits of DNA are the pages of the human instruction manual. Read this great review featuring Eric S. Lander from MIT, Harvard, and the Broad Institute in Cambridge to see how far we've come and what the future of genomics holds.

The shape of cancer genomics may be a new calling card for 3D oncologic imaging. Studying the formation of cancer cell genomes could potentially provide more information about a patient's cancer than just focusing on genetic expression. Scientists at McGill University in Montreal are finding that the form of a cancer cell genome can even tell them what subtype of cancer a patient has.

Biopharmaceutical giant Bristol-Myers Squibb now holds the power on a pipeline of neurodegenerative disease therapies after buying San Francisco-based iPierian for $175 million.

Drug policy in the European Union could change in the not too distant future depending on a vote regarding a law proposed to discourage pharmaceutical companies from playing favorites when it comes to clinical trials.

Biological engineers at the Massachusetts Institute of Technology have developed a method to adapt MRI to visualize gene activity in an effort to better understand the processes behind the formation of memories.

A tiny molecular imaging system could be used on the field to measure brain injury or in the lab to capture individual molecules that betray the biology of cancer, neurodegenerative diseases such as Alzheimer's and viruses like human immunodeficiency virus (HIV). 

A PET/CT study followed 40 sufferers of heart attacks and just as many matched controls imaged with conventional coronary angiography and sodium fluoride PET/CT to gauge vulnerable plaques and see potential risk of heart attack.